Application 065226
- Type
- ANDA
- Sponsor
- HOSPIRA INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CEFAZOLIN SODIUM | CEFAZOLIN SODIUM | INJECTABLE;INJECTION | EQ 500MG BASE/VIAL | No | No |
| 002 | CEFAZOLIN SODIUM | CEFAZOLIN SODIUM | INJECTABLE;INJECTION | EQ 1GM BASE/VIAL | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0409-0805 | Cefazolin | CEFAZOLIN | Hospira, Inc. | ANDA | Current |
| 50090-2714 | Cefazolin | CEFAZOLIN | A-S Medication Solutions | ANDA | Current |
| 52584-023 | Cefazolin | Cefazolin Sodium | General Injectables & Vaccines, Inc | ANDA | Current |
| 55154-6668 | Cefazolin | Cefazolin | Cardinal Health | ANDA | Current |
| 55154-7826 | Cefazolin | Cefazolin | Cardinal Health | ANDA | Current |
| 60505-0749 | Cefazolin | CEFAZOLIN | Apotex Corporation | ANDA | Current |